Latest Daiichi Sankyo Stories
RnRMarketResearch.com adds “Dyslipidemia – Pipeline Review, H1 2015” to its store.
LONDON, January 26, 2015 /PRNewswire/ -- Prospects for Leading Companies Report Details World OTC pharmaceuticals - your guide to technologies,
RnRMarketResearch.com adds “Constipation – Pipeline Review, H1 2015” to its store.
MUMBAI, January 21, 2015 /PRNewswire/ -- The launch of Remicade biosimilar in Dec-2014 in the Japan pharma market demonstrated its changing regulatory environment; it is
PARSIPPANY, N.J., Jan. 9, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc. ("the Company") announced today that it has reached a civil settlement with the U.S.
Permanent, product-specific code for iron deficiency anemia drug will streamline provider billing and reimbursement SHIRLEY, N.Y., Dec.
LONDON, December 12, 2014 /PRNewswire/ -- Opportunities for Leading Companies Report Details Melanoma Drugs - new study showing you trends,
DALLAS, December 11, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Breast Cancer - Pipeline Review, H2 2014" and "Adrenocortical Carcinoma (Adrenal Cortex Cancer) -
Findings on intravenous iron therapy in iron deficiency anemia presented SAN FRANCISCO, Dec.
- The parings of haberdine; also, any kind of fragments.